For example, mutations in the genes encoding isocitrate dehydrogenase (IDH) 1 and 2 (IDH1 and IDH2) account for approximately 80% of grade-2 gliomas and represent one of the fundamental and earliest molecular events in the genesis of these tumors [14,15,16,17]. This evidence concerns the gene IDH2 and central nervous system cancer.